Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors

por Ponomarenko, Dmitry M., Klimova, Irina D., Chapygina, Yulia A., Dvornichenko, Viktoria V., Zhukova, Natalia V., Orlova, Rashida V., Manikhas, Georgy M., Zyryanov, Alexandr V., Burkhanova, Lilya A., Badrtdinova, Irina I., Oshchepkov, Basile N., Filippova, Elena V., Orlov, Sergei V., Kolesnikov, Sergei I., Sufianov, Albert A., Baum, Svetlana R., Zaitzeva, Olga Y., Komissarov, Andrey B., Grudinin, Mikhail P., Kiselev, Oleg I., Tsyb, Anatoly F., Venanzi, Franco, Shcherbinina, Vita, Chursov, Andrey, Gabai, Vladimir L., Shneider, Alexander M.
Publicado no Oncotarget (2017)